Invex Therapeutics Ltd Ordinary Shares (ASX:IXC)

APAC company
add to virtual portfolio
This share can be held in
Trading AccountISAJISASIPP

Share Price Chart

- Chart currently unavailable -

Market Info - IXC

  • Market Open Price0.00
  • Previous Close0.00
  • Volume-
  • 52w Low/High-
  • Last Trade Price0.00
  • Bid/Ask Price0.00

Company Info - IXC

  • Market CapAUD0.000m
  • SymbolASX:IXC
  • IndustryHealthcare
  • SectorBiotechnology
  • Currency
  • ISINAU0000048621

Company Profile

Invex Therapeutics Ltd is a biopharmaceutical company, focused on the research and development of Exenatide as a treatment for neurological conditions such as Idiopathic Intracranial Hypertension (IIH), traumatic brain injury, or acute stroke. Its another program under development is Presendin which can be used for disabling headaches and permanent vision loss in females. Geographically, it operates only in Australia.

Latest IXC news

Currently there for this company. Visit our news hub for other news .